ALLOX

Barcelona, ES · 1 known investors

ALLOX develops an AI-enabled platform that uses high-throughput genomics and machine learning to discover biophysical parameters governing protein function for drug discovery. The company focuses on identifying allosteric drug targets to enable development of therapies for previously undruggable proteins.